Purple Innovation, Inc. current report, 13 November 2020

Business Context and Reporting Period

This Form 8-K was filed by Purple Innovation, Inc. (PRPL) on November 13, 2020. The report addresses the voluntary withdrawal of the Company's warrants from listing on The Nasdaq Stock Market following a scheduled redemption event.

Key Financial Metrics

The filing does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and securities listing status.

Material Changes

  • Warrant Redemption: The Company previously notified holders that Public Warrants and Incremental Loan Warrants would be redeemed on November 30, 2020.
  • Remaining Warrant Structure: Post-redemption, approximately 8.5 million Sponsor Warrants (exercisable for 4.25 million shares) will remain outstanding, held by only 16 warrant holders.
  • Delisting Decision: Due to the limited number of remaining holders and potential liquidity constraints, the Board of Directors determined to voluntarily delist the warrants from Nasdaq.

Outlook, Risks, and Management Commentary

  • Liquidity Risk: Management anticipates that trading activity in the warrants will be limited following the redemption, which could negatively affect liquidity.
  • Future Trading Venue: The Company expects the last day of trading on Nasdaq to be on or about November 30, 2020. Thereafter, warrants are expected to trade over-the-counter (OTC), though the Company provides no assurance that OTC trading will continue.
  • Common Stock Status: The delisting of warrants will not affect the listing of the Company's Class A common stock (PRPL) on Nasdaq.
  • Regulatory Filing: The Company intends to file a Form 25 with the SEC on November 30, 2020, with the delisting effective ten days thereafter.

Investor Verification Checklist

  • Confirm the exact date of the last day of trading for PRPLW on Nasdaq (expected November 30, 2020).
  • Verify the status of the Form 25 filing to confirm the official delisting date.
  • Monitor OTC market availability for PRPLW post-delisting, as trading is not guaranteed.
  • Review the terms of the remaining Sponsor Warrants regarding cashless exercise and transfer restrictions.